Sexual Health & Medical Wellness Ozempic’s hidden pregnancy risk few women know about May 22, 2026 Susilo Ahmad A groundbreaking study, spearheaded by Flinders University and published in the esteemed Medical Journal of Australia, has cast a critical spotlight on the prescribing patterns of GLP-1 receptor agonists—a class…
Sexual Health & Medical Wellness Ozempic’s hidden pregnancy risk few women know about May 13, 2026 Susilo Ahmad A groundbreaking new study from Flinders University has brought to light a critical public health concern, revealing that a significant majority of Australian women of reproductive age who are prescribed…
Sexual Health & Medical Wellness Ozempic’s hidden pregnancy risk few women know about May 5, 2026 Susilo Ahmad The Rise of GLP-1 Agonists: A Medical Revolution Glucagon-like peptide-1 (GLP-1) receptor agonists represent a transformative class of medications that have reshaped the treatment landscape for both type 2 diabetes…
Sexual Health & Medical Wellness Ozempic’s hidden pregnancy risk few women know about April 7, 2026 Susilo Ahmad A groundbreaking study spearheaded by Flinders University researchers has revealed a critical oversight in the burgeoning use of GLP-1 receptor agonists, a class of medications increasingly popular for weight loss,…
Sexual Health & Medical Wellness Ozempic’s hidden pregnancy risk few women know about March 31, 2026 Susilo Ahmad A new study, published in the Medical Journal of Australia, has cast a critical spotlight on the widespread use of GLP-1 receptor agonists among Australian women of childbearing age, revealing…
Sexual Health & Medical Wellness Ozempic’s hidden pregnancy risk few women know about March 24, 2026 Susilo Ahmad A new and significant study led by Flinders University researchers has cast a critical spotlight on the prescribing patterns of GLP-1 receptor agonists, a class of medications increasingly popular for…